Ultragenyx agrees to sell rare pediatric priority review voucher for $203 millionOct 14M&AUltragenyx Pharmaceutical Inc
FDA grants full approval to Ultragenyx gene therapy FAYUVI for Sanfilippo syndrome Type ASep 17Regulatory milestoneUltragenyx Pharmaceutical Inc
Ultragenyx reports Q2 2026 results, cites two PDUFA dates and Angelman readout aheadAug 4Quarterly updateapazunersenrebisufligene etisparvovec